United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex

Annals of Thoracic Surgery

Volumn 86, Issue 1, 2008, Pages 46-55

  Svensson, Lars G ^a   Dewey, Todd ^b   Kapadia, Samir ^a   Roselli, Eric E ^a   Stewart, Alan ^c   Williams, Matt ^c   Anderson, William N ^d   Brown, David ^b   Leon, Marty ^c   Lytle, Bruce ^a   Moses, Jeffrey ^c   Mack, Michael ^b   Tuzcu, Murat ^a   Smith, Craig ^c  

^a Center for Aortic Surgery   (United States)

^b MEDICAL CITY DALLAS HOSPITAL   (United States)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

STAINLESS STEEL;

AGED; AORTA VALVE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON CATHETER; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY STENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GRAFT PERFUSION; HEART VALVE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; INVASIVE PROCEDURE; KAPLAN MEIER METHOD; MALE; MEDICAL DOCUMENTATION; MITRAL VALVE REGURGITATION; PERICARDIUM; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TRANSAPICAL LEFT VENTRICULAR INSERTION; UNITED STATES; AGE; ANGIOGRAPHY; BALLOON DILATATION; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HOSPITALIZATION; INSTRUMENTATION; METHODOLOGY; MORTALITY; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; STENT; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC VALVE STENOSIS; BALLOON DILATATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 47049087117     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.049     Document Type: Article

References (27)

1. Varadarajan P., Kapoor N., Bansal R.C., and Pai R.G. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 82 (2006) 2111-2115
2. Pai R.G., Kapoor N., Bansal R.C., and Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 82 (2006) 2116-2122
3. Soler-Soler J., and Galve E. Worldwide perspective of valve disease. Heart 83 (2000) 721-725
4. Stuge O., and Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 132 (2006) 1258-1261
5. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003) 1231-1243
6. Lindroos M., Kupari M., Heikkilä J., and Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21 (1993) 1220-1225
7. Pellikka P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111 (2005) 3290-3295
8. Bonow R.O., Carabello B., de Leon A.C., et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 7 (1998) 672-707
9. Banbury M.K., Cosgrove III D.M., Thomas J.D., et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 73 (2002) 1460-1465
10. Blackstone E.H., Cosgrove D.M., Jamieson W.R., et al. Prosthesis size and long-term survival after aortic valve replacement. J Thorac Cardiovasc Surg 126 (2003) 783-796
11. Svensson L.G., Blackstone E.H., and Cosgrove III D.M. Surgical options in young adults with aortic valve disease. Curr Probl Cardiol 28 (2003) 417-480
12. Schwarz F., Baumann P., Manthey J., et al. The effect of aortic valve replacement on survival. Circulation 66 (1982) 1105-1110
13. Smith N., McAnulty J.H., and Rahimtoola S.H. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 58 (1978) 255-264
14. Otto C.M., Mickel M.C., Kennedy J.W., et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 89 (1994) 642-650
15. Andersen H.R., Knudsen L.L., and Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 13 (1992) 704-708
16. Walther T., Simon P., Dewey T., et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116 11 suppl (2007) I240-I245
17. Dewey T.M., Walther T., Doss M., et al. Transapical aortic valve implantation: an animal feasibility study. Ann Thorac Surg 82 (2006) 110-116
18. Lichtenstein S.V., Cheung A., Ye J., et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114 (2006) 591-596
19. Webb J.G., Pasupati S., Humphries K., et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116 (2007) 755-763
20. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (2006) 842-850
21. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002) 3006-3008
22. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-703
23. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114 (2006) 1616-1624
24. Leon M.B., Kodali S., Williams M., et al. Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. Semin Thorac Cardiovasc Surg 18 (2006) 165-174
25. Svensson L.G. Aortic valve stenosis and regurgitation: an overview of management. J Cardiovasc Surg (Torino) 49 (2008) 297-303
26. Vassiliades Jr. T.A., Block P.C., Cohn L.H., et al. The clinical development of percutaneous heart valve technology. J Thorac Cardiovasc Surg 129 (2005) 970-976
27. Dewey TM, Brown D, Das T, et al. High-risk patients with symptomatic aortic stenosis referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg (in press).